GILENYA: payments to doctors
Payments that named GILENYA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.9M
- Providers
- 3,314
- Transactions
- 16,471
- Average per transaction
- $179
The per-transaction average — $179 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,314 providers the average total is $889, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novartis | $2,900,937 | 98.4% |
| Novartis Pharma AG | $46,206 | 1.6% |